This study aimed to know the association between duration of HU administration prior to IM treatment and MMR achievement in chronic-phase CML, as well as role the of ROS, HIF-1α and P-gp in the process. This evidence concerns the gene PGP and chronic myelogenous leukemia, BCR-ABL1 positive.